STOCK TITAN

[Form 4] Weyco Group Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Kevin Schiff, identified as an officer (VP, President - Florsheim) of Weyco Group Inc. (WEYS), reported acquiring 1,695 shares of the issuer on 08/25/2025 at a price of $0, bringing his total beneficial ownership to 29,250 shares. The Form 4 shows this non‑derivative transaction and lists his existing derivative holdings in Weyco stock options.

The filing also discloses four series of outstanding stock options exercisable into common stock: 1,200 shares at $18 (exp. 08/26/2030), 2,401 shares at $24 (exp. 08/25/2031), 2,341 shares at $28.83 (exp. 08/25/2032), and 3,121 shares at $25.79 (exp. 08/25/2033). Each option grant vests at 20% per year for five years beginning on the listed grant date for each series.

Kevin Schiff, indicato come dirigente (VP, President - Florsheim) di Weyco Group Inc. (WEYS), ha dichiarato l'acquisto di 1.695 azioni dell'emittente in data 25/08/2025 al prezzo di $0, portando la sua partecipazione complessiva a 29.250 azioni. Il Modulo 4 segnala questa operazione non‑derivata e riporta inoltre le sue posizioni in derivati, costituite da opzioni su azioni Weyco.

La comunicazione indica anche quattro serie di opzioni azionarie esercitabili in azioni ordinarie: 1.200 azioni a $18 (scad. 26/08/2030), 2.401 azioni a $24 (scad. 25/08/2031), 2.341 azioni a $28,83 (scad. 25/08/2032) e 3.121 azioni a $25,79 (scad. 25/08/2033). Ogni tranche di opzioni matura al 20% all'anno per cinque anni, a partire dalla data di assegnazione indicata per ciascuna serie.

Kevin Schiff, identificado como ejecutivo (VP, President - Florsheim) de Weyco Group Inc. (WEYS), informó la adquisición de 1.695 acciones del emisor el 25/08/2025 a un precio de $0, elevando su participación total a 29.250 acciones. El Formulario 4 refleja esta operación no derivada y también enumera sus posiciones en derivados, consistentes en opciones sobre acciones de Weyco.

La presentación revela además cuatro series de opciones sobre acciones ejercitables en acciones comunes: 1.200 acciones a $18 (venc. 26/08/2030), 2.401 acciones a $24 (venc. 25/08/2031), 2.341 acciones a $28,83 (venc. 25/08/2032) y 3.121 acciones a $25,79 (venc. 25/08/2033). Cada concesión de opciones vence en un 20% anual durante cinco años, a partir de la fecha de otorgamiento indicada para cada serie.

케빈 쉬프(Kevin Schiff)는 Weyco Group Inc.(WEYS)의 임원(VP, President - Florsheim)으로서 2025-08-25에 발행회사의 1,695주를 주당 $0에 취득했다고 보고했으며, 이로써 그의 총 실질 보유주는 29,250주가 되었습니다. 제출된 Form 4에는 이 비파생(현물) 거래가 표시되어 있으며, Weyco 주식 옵션 등 그의 기존 파생상품 보유도 기재되어 있습니다.

공시에 따르면 보통주로 전환 가능한 네 개의 옵션 시리즈가 남아 있습니다: $18에 1,200주(만기 2030-08-26), $24에 2,401주(만기 2031-08-25), $28.83에 2,341주(만기 2032-08-25), $25.79에 3,121주(만기 2033-08-25). 각 옵션 부여분은 지급일로부터 5년 동안 연 20%씩 베스팅됩니다.

Kevin Schiff, identifié comme dirigeant (VP, President - Florsheim) de Weyco Group Inc. (WEYS), a déclaré l'acquisition de 1 695 actions de l'émetteur le 25/08/2025 au prix de 0 $, portant sa détention effective totale à 29 250 actions. Le formulaire 4 signale cette transaction non dérivée et indique également ses positions en dérivés, sous forme d'options sur actions Weyco.

Le dépôt révèle en outre quatre séries d'options en circulation exerçables en actions ordinaires : 1 200 actions à 18 $ (échéance 26/08/2030), 2 401 actions à 24 $ (échéance 25/08/2031), 2 341 actions à 28,83 $ (échéance 25/08/2032) et 3 121 actions à 25,79 $ (échéance 25/08/2033). Chaque attribution d'options acquiert des droits à hauteur de 20 % par an pendant cinq ans, à compter de la date d'attribution indiquée pour chaque série.

Kevin Schiff, als leitender Angestellter (VP, President - Florsheim) von Weyco Group Inc. (WEYS) angegeben, meldete den Erwerb von 1.695 Aktien des Emittenten am 25.08.2025 zum Preis von $0, womit seine gesamte wirtschaftliche Beteiligung auf 29.250 Aktien anstieg. Das Formular 4 zeigt diese nicht‑derivative Transaktion und listet zudem seine bestehenden Derivatebestände in Form von Weyco‑Aktienoptionen auf.

Die Einreichung offenbart außerdem vier ausstehende Optionsserien, die in Stammaktien ausgeübt werden können: 1.200 Aktien zu $18 (Laufzeit bis 26.08.2030), 2.401 Aktien zu $24 (Laufzeit bis 25.08.2031), 2.341 Aktien zu $28,83 (Laufzeit bis 25.08.2032) und 3.121 Aktien zu $25,79 (Laufzeit bis 25.08.2033). Jede Optionszuteilung vestet mit 20% pro Jahr über fünf Jahre, beginnend am angegebenen Zuteilungsdatum der jeweiligen Serie.

Positive
  • Insider ownership increased by 1,695 shares, bringing total beneficial ownership to 29,250 shares.
  • Clear option disclosure with exercise prices and expirations, and explicit vesting schedules of 20% per year for five years, enhancing transparency.
Negative
  • None.

Insights

TL;DR: Routine officer share acquisition and disclosure of outstanding option grants; increases insider ownership but appears administrative rather than market-moving.

The Form 4 documents an acquisition of 1,695 common shares at a reported price of $0, raising the reporting person’s beneficial ownership to 29,250 shares. The filing also inventories four option tranches with exercise prices from $18.00 to $28.83 and expirations through 2033, each vesting 20% annually over five years. For investors, this confirms insider stake and the timeline for potential option exercises, but contains no earnings, disposition of large holdings, or unusual compensation terms disclosed in the filing.

TL;DR: Standard Section 16 disclosure showing an officer’s issuance/acquisition and scheduled option vesting; governance implications limited and routine.

The report identifies Kevin Schiff as an officer (VP, President - Florsheim) and provides clear disclosure of both non‑derivative and derivative holdings. The 20% per year vesting schedules are explicitly stated for each option grant, providing transparency on future insider alignment with long‑term performance. The filing contains no indication of special arrangements, related‑party transfers, or unusual accelerating events; it meets routine reporting expectations under Section 16.

Kevin Schiff, indicato come dirigente (VP, President - Florsheim) di Weyco Group Inc. (WEYS), ha dichiarato l'acquisto di 1.695 azioni dell'emittente in data 25/08/2025 al prezzo di $0, portando la sua partecipazione complessiva a 29.250 azioni. Il Modulo 4 segnala questa operazione non‑derivata e riporta inoltre le sue posizioni in derivati, costituite da opzioni su azioni Weyco.

La comunicazione indica anche quattro serie di opzioni azionarie esercitabili in azioni ordinarie: 1.200 azioni a $18 (scad. 26/08/2030), 2.401 azioni a $24 (scad. 25/08/2031), 2.341 azioni a $28,83 (scad. 25/08/2032) e 3.121 azioni a $25,79 (scad. 25/08/2033). Ogni tranche di opzioni matura al 20% all'anno per cinque anni, a partire dalla data di assegnazione indicata per ciascuna serie.

Kevin Schiff, identificado como ejecutivo (VP, President - Florsheim) de Weyco Group Inc. (WEYS), informó la adquisición de 1.695 acciones del emisor el 25/08/2025 a un precio de $0, elevando su participación total a 29.250 acciones. El Formulario 4 refleja esta operación no derivada y también enumera sus posiciones en derivados, consistentes en opciones sobre acciones de Weyco.

La presentación revela además cuatro series de opciones sobre acciones ejercitables en acciones comunes: 1.200 acciones a $18 (venc. 26/08/2030), 2.401 acciones a $24 (venc. 25/08/2031), 2.341 acciones a $28,83 (venc. 25/08/2032) y 3.121 acciones a $25,79 (venc. 25/08/2033). Cada concesión de opciones vence en un 20% anual durante cinco años, a partir de la fecha de otorgamiento indicada para cada serie.

케빈 쉬프(Kevin Schiff)는 Weyco Group Inc.(WEYS)의 임원(VP, President - Florsheim)으로서 2025-08-25에 발행회사의 1,695주를 주당 $0에 취득했다고 보고했으며, 이로써 그의 총 실질 보유주는 29,250주가 되었습니다. 제출된 Form 4에는 이 비파생(현물) 거래가 표시되어 있으며, Weyco 주식 옵션 등 그의 기존 파생상품 보유도 기재되어 있습니다.

공시에 따르면 보통주로 전환 가능한 네 개의 옵션 시리즈가 남아 있습니다: $18에 1,200주(만기 2030-08-26), $24에 2,401주(만기 2031-08-25), $28.83에 2,341주(만기 2032-08-25), $25.79에 3,121주(만기 2033-08-25). 각 옵션 부여분은 지급일로부터 5년 동안 연 20%씩 베스팅됩니다.

Kevin Schiff, identifié comme dirigeant (VP, President - Florsheim) de Weyco Group Inc. (WEYS), a déclaré l'acquisition de 1 695 actions de l'émetteur le 25/08/2025 au prix de 0 $, portant sa détention effective totale à 29 250 actions. Le formulaire 4 signale cette transaction non dérivée et indique également ses positions en dérivés, sous forme d'options sur actions Weyco.

Le dépôt révèle en outre quatre séries d'options en circulation exerçables en actions ordinaires : 1 200 actions à 18 $ (échéance 26/08/2030), 2 401 actions à 24 $ (échéance 25/08/2031), 2 341 actions à 28,83 $ (échéance 25/08/2032) et 3 121 actions à 25,79 $ (échéance 25/08/2033). Chaque attribution d'options acquiert des droits à hauteur de 20 % par an pendant cinq ans, à compter de la date d'attribution indiquée pour chaque série.

Kevin Schiff, als leitender Angestellter (VP, President - Florsheim) von Weyco Group Inc. (WEYS) angegeben, meldete den Erwerb von 1.695 Aktien des Emittenten am 25.08.2025 zum Preis von $0, womit seine gesamte wirtschaftliche Beteiligung auf 29.250 Aktien anstieg. Das Formular 4 zeigt diese nicht‑derivative Transaktion und listet zudem seine bestehenden Derivatebestände in Form von Weyco‑Aktienoptionen auf.

Die Einreichung offenbart außerdem vier ausstehende Optionsserien, die in Stammaktien ausgeübt werden können: 1.200 Aktien zu $18 (Laufzeit bis 26.08.2030), 2.401 Aktien zu $24 (Laufzeit bis 25.08.2031), 2.341 Aktien zu $28,83 (Laufzeit bis 25.08.2032) und 3.121 Aktien zu $25,79 (Laufzeit bis 25.08.2033). Jede Optionszuteilung vestet mit 20% pro Jahr über fünf Jahre, beginnend am angegebenen Zuteilungsdatum der jeweiligen Serie.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schiff Kevin

(Last) (First) (Middle)
333 W. ESTABROOK BOULEVARD

(Street)
GLENDALE WI 53212

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
WEYCO GROUP INC [ WEYS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, PRESIDENT - FLORSHEIM
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 A 1,695 A $0 29,250 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $18 08/26/2021(1) 08/26/2030 Common Stock 1,200 1,200 D
Stock Option $24 08/25/2022(2) 08/25/2031 Common Stock 2,401 2,401 D
Stock Option $28.83 08/25/2023(3) 08/25/2032 Common Stock 2,341 2,341 D
Stock Option $25.79 08/25/2024(4) 08/25/2033 Common Stock 3,121 3,121 D
Explanation of Responses:
1. 20% per year for 5 years beginning 08/26/2021
2. 20% per year for 5 years beginning 08/25/2022
3. 20% per year for 5 years beginning 08/25/2023
4. 20% per year for 5 years beginning 08/25/2024
/s/ Kevin Schiff 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Kevin Schiff report on Form 4 for WEYS?

He reported acquiring 1,695 shares of Weyco Group Inc. common stock on 08/25/2025 at a reported price of $0.

How many Weyco shares does Kevin Schiff beneficially own after the reported transaction?

Following the transaction he beneficially owns 29,250 shares.

What stock option tranches does the Form 4 disclose for Kevin Schiff?

The filing lists options for 1,200 shares at $18 (exp. 08/26/2030), 2,401 at $24 (exp. 08/25/2031), 2,341 at $28.83 (exp. 08/25/2032), and 3,121 at $25.79 (exp. 08/25/2033).

What are the vesting terms for the reported option grants?

Each option grant vests at 20% per year for five years, with vesting schedules beginning on the respective grant dates shown in the filing.

What is Kevin Schiff's role at Weyco as shown on the Form 4?

He is reported as an officer with the title VP, President - Florsheim.
Weyco Group Inc

NASDAQ:WEYS

WEYS Rankings

WEYS Latest News

WEYS Latest SEC Filings

WEYS Stock Data

292.95M
5.99M
36.38%
26.77%
0.64%
Footwear & Accessories
Wholesale-apparel, Piece Goods & Notions
Link
United States
GLENDALE